Clinical trials are complex undertakings and whether by necessity or strategic design, an increasing number of trials are now outsourced by pharma and biotech firms. This often requires the use of multiple partners to complete all aspects of a clinical trial. Greg Guarasci (Senior Vice President, Operations and General Partner) is joined by Lara Longpre of Jennerex Biotherapeutics to consider if these multiple partnerships are the way of the future,


Explore related content and topics